Lee Buckler

Lee Buckler is a declared insider of RepliCel Life Sciences Inc., with filings sourced from SEDI. The record holds 3 filings, for trades running from 10 August 2016 to 16 February 2021.

Purchases make up the whole of the open-market record (2 purchases, €897). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2021: 2 purchases and no sales on the market.

The latest filing, published on 16 February 2021, reports an open-market purchase of €766 in RepliCel Life Sciences Inc. The median gap between a trade and its publication by SEDI is 4 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.